NXGLNexGel Inc Common Stock

NAS · US · Healthcare · Medical Instruments & Supplies · nexgel.com

0.3300USD-18.30%Mkt Cap: 3.22M $P/E: —3d ago

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It oper…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap3.22M $

Enterprise Value11.26M $

Revenue (TTM)12.07M $

Gross Profit4.51M $

Net Income (TTM)-3.00M $

Revenue/Share1.459 USD

Last Price0.3300 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees19

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)0.97

PEG—

EV/EBITDA-2.65

EV/Revenue0.93

P/S0.31

P/B0.82

EPS (TTM)-0.71

EPS (Forward)0.40

52W Range

0.30031% of range2.890

52W High2.890 USD

52W Low0.3003 USD

Profitability

Gross Margin39.48%

Oper. Margin-67.96%

EBITDA Margin-35.23%

Profit Margin-26.27%

ROE-67.28%

ROA-28.68%

Growth

Revenue Growth27.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.31M $

CapEx (TTM)68.00K $

FCF Margin70.27%

FCF Yield263.61%

Net Debt6.97M $

Net Debt/EBITDA-1.64

Balance Sheet

Debt/Equity0.69

Current Ratio0.43

Quick Ratio0.11

Book Value/Sh0.4710 USD

Cash/Share0.0500 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)2.000 USD

Upside (mean)+506.1%

Target Range2.000 USD – 2.000 USD

# Analysts1

Ownership

Shares Out.9.75M

Float7.55M

Insiders13.81%

Institutions13.67%

Short Interest

Short Ratio1.2d

Short % Float1.67%

Short % Out.1.42%

Shares Short131.23K

Short (prev mo.)176.79K

Technical

SMA 500.4782 (-31.0%)

SMA 2001.006 (-67.2%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)275.26K

Avg Vol (10d)783.72K

Technical Indicators

RSI (14)40.6

MACD-0.0211

MACD Signal-0.0212

MACD Hist.+0.0001

BB Upper0.5222 USD

BB Middle0.4194 USD

BB Lower0.3166 USD

BB Width49.03%

ATR (14)0.0690 USD

Vol Ratio (20d)0.96x